Regular inhaled beta-agonist treatment in bronchial asthma
- 8 December 1990
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 336 (8728), 1391-1396
- https://doi.org/10.1016/0140-6736(90)93098-a
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.Thorax, 1988
- Asthma drug therapy trends in the United States, 1972 to 1985Journal of Allergy and Clinical Immunology, 1987
- HAS THE MANAGEMENT OF ASTHMA IMPROVED?The Lancet, 1987
- Use of anti-asthma drugs in New Zealand.Thorax, 1987
- Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: A comparison between budesonide and terbutalineJournal of Allergy and Clinical Immunology, 1985
- Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects.Thorax, 1982
- Regular versus symptomatic aerosol bronchodilator treatment of asthmaRespiratory Medicine, 1981
- Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthmaRespiratory Medicine, 1978
- Asthma induced by adrenergic aerosolsJournal of Allergy, 1970
- Adverse effects of inhalation of excessive amounts of nebulized isoproterenol in status asthmaticusJournal of Allergy, 1969